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Summary
Backgtound Deep venous thrombosis is a common disease, with
genetic and acquired nsk factors Many patients have a history of
minor events (short penods of iramobihsaüon such äs prolonged travel,
short illness. ramor surgery or injunes) before onset of venous throm-
bosis However. the role of these mmor events has received httle formal
study Also, we do not know how mmor events might mteract with the
presence of genetic prothrombotic defects (factor V Leiden mutation
factor II mutation, protein C S and antithrombin deficiency) Patients
and Methods On the basis of case-control data from a thrombosis
Service m the Netherlands we added a follow-up penod for a case-
cross-over analysis of minor events äs nsk factors, and a case only
analysis toi the mteraction with factor V Leiden A total of 187 patients
with first. objectively diagnosed venous thrombosis of the legs, aged
15-70, without underlymg malignanues and without major acquired
nsk factors entered the study Tor the analy sis of minor events in the
case-cross-over analysis we used a matched odds ratio, m the case
only analysis we used the multiphcative s\nergy mdex Results In
32 6% ot the 187 patients wi th deep venous thrombosis who did not
have major acquired nsk tactors, mmor events were the only external
nsk factors Minor events mcreased the nsk of thrombosis about 3-fold
äs estimated m the case-cross-over analysis (odds ratio 2 9, 95% con-
fidence interval l 5-5 4) The synergy mdex between minor events and
factor V Leiden mutation m the case-only analysis was 0 7 (95% con-
fidence interval 03-15) Therefore, persons with factor V Leiden
mutation who expenence a minor event will have an estimated nsk
mcrease of about 17-fold. which exceeds the sum of the mdividual nsk
factors Condusions Mmor events are hkelv to play an important
role m the development of deep venous thrombosis, especially m the
presence of genetic prothrombotic conditions
Introduction
The mcidence of deep venous thrombosis (DVT) m the general
population is estimated to be l per 1000 per year Hereditary coagula-
tion defects that are associated with an mcreased nsk are protein C,
protein S, antithrombin deficiency, factor II (20210 G to A) mutation,
and APC resistance (Factor V Leiden mutation) ( l ) Acquired condi-
tions that promote DVT mclude prolonged immobihsation, major
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injunes and surgery The combination of acquired and hereditary nsk
factors may lead to the highest nsks In a substantial number ot patients
the underlymg cause remains unresolved, however
Many patients with DVT. when asked, have a recent history of mi-
nor events stram or mmor injunes due to effort. short illness or short
immobilisation while travellmg Smce the nsk brought about by major
surgery and trauma, plaster casts and prolonged immobilisation is sub-
stantial, mmor illnesses and mterventions might prove to be moderate
nsk factors Nevertheless, mmor events have only received anecdotal
attention m the hterature and very httle formal study except for (air)
travel (2-4) Our study was performed to mvestigate the role of minor
events m DVT, and their possible mteraction with genetic prothrom-
botic defects We reanalysed data from the Leiden Thrombophilia
Study (LETS) (5) in which mmor events, generally occumng within
two weeks before the DVT, had been noted m patient discharge letters
Firstly, we performed a case cross-over study four years after the first
venous thrombosis patients were asked agam if thev had expenenced a
minor event m a new and arbitrary two week penod This permitted us
to use the cases äs their own controls Secondly we studied the svner-
gy between mmor events and tactor V Leiden m a case only analysis
Methods
The present stud\ was an extension of the Leiden Thrombophilia Studv
(LETS) (5) The LETS studv was pertormed between 1988 and 1993 and was a
population based case control studv on hereditarv venous thrombosis Patients
were selected trom the files of the anticoagulant clmics m Leiden Amsterdam
and Rotterdam Patients with known malignant disorders were excluded In
total 474 consecuti\e outpatients were mcluded (median age 47) Patients were
referred tor diagnosis after a first objectivelv confirmed episode of DVT All
patients were seen bv one of the mam mvestigators and completed a Standard
questionnaire Se\eral major acquired thrombosis nsk tactors were recorded
prolonged immobilisation surgery hospitahsation without surgerv pregnana
and postpartum penod Genetic and biochemical nsk tactors analvsed in i t ia l
ly or later on were tactor V Leiden mutation tactor II (20210 A/G) mutation
and deficiencv ot protein C protein S or antithrombin
Although the LETS questionnaire did not melude Standard questions tor
mmor events these were reguiarly mentioned äs a possible causattve tactor
Most records trom the patients selected m Leiden contamed both extra
comments ot the imestigator and hospital discharge letters The records trom
Amsterdam and Rotterdam did not have this extra Information trom the
discharge letters For our present study, theretore onlv the Leiden records
were used
We selected patients without any major acquired nsk tactor, onlv
patients without an e\ent or patients with a mmor event occumng wi th in two
weeks betöre the DVT were selected Mmor events were defmed äs bed rest
more man 12 h j dav tor two or more consecutive days hcavy phvsical exer
tion mmor trauma minor surgery or prolonged travel (by car bus or plane)
leadmg to dimimshed or pamtul usc ot one ot the extrcmities
Two separate analvses were pertormed FirstK to estimate the relative nsk
ot the mmor e\ent itselt we apphed a tase-crossover study, usmg the cases öl
this study äs their own control This was accomplished dunng the tollow-up ot
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these patients, on average four years after the initial mclusion: patients were
asked if a mmor event had occurred in the arbitrary two weeks penod before
they had been approached for this follow-up The follow-up was by ques-
tionnaire, augmented by telephone inquines: patients could mdicate on the
questionnaire whether any mmor event had happened recently, and they were
subsequently phoned to ask the details and time wmdow of these mmorevents
Of each patient we therefore knew not only whether he or she had expenenced
a mmor event m the (approximately) two weeks before the DVT, but also m an
arbitrary two week penod at another time m their life This permits a matched
case-control analysis to see how much more frequent such events are m the
weeks preceding DVT than in another penod m the same patients life
Secondly. the mmor events preceding the ongmal venous thrombosis were
studied m their combination with the presence of factor V Leiden The extern of
mteraction between the exposure ot mmor events and the presence ot Factor V
Leiden on the nsk for thrombosis was assessed by a case-only study (6, 7, 8)
The case-only study relies on the assumption that the two factors ot mterest
are mdependently distnbuted m the general population That is a reasonable
assumption for genetic risk factors and mmor events for mmor events that
precede a first DVT in a patient it is likely that their occurrence, i e whether or
not the patient engaged m plane travel before a first DVT, was not mfluenced
by the presence or absence of a hitherto unknown genetic factor (factor V
Leiden and the prothroVnbm mutation was unknown at the time of our original
investigation) DVT cases are divided mto those with and without mmor events
The odds ratio of the tactor V Leiden is then an estimate of the synergy mdex
on the multiphcative scale This synergy mdex is the factor by which the jomt
relative nsks ot genetic defects and mmor events have to be multiphed
Resuits
We mcluded 271 patients from the Leiden part of the LETS study
The male/female ratio was 120/151, with mean age at diagnosis ot
the thrombosis 42 years (ränge 15-69, SD 14) Of the 271 patients
84 were excluded because of pregnancy or postpartum. major opera-
tions, prolonged immobilisaüon (more than two weeks), or hospital
stay for more than three days preceding their DVT
Ot the remaimng 187 patients. 61 had expenenced mmor events
(32 6%), the other 126 patients had no recorded event Table l shows
the male/female ratio. mean age and ränge of the cases with <md
without mmor events
Table 2 summanses the charactenstics of the mmor events The
majonty was bed rest at home for vanous conditions, includmg mmor
Table I Sex and age charactenstics ot the 187 patients mcluded m the study
male:female mean age + SD ränge
mmor events (n= 61) 3 1 3 0 43 3 ±13 4 146-687
no mmor events (n= 126) 5 5 7 1 42 8 +.14 6 153 -673
Table 2 Charactenstics of the mmor events preceding DVT
Minor event Patients Remark
Table 3 Coagulation abnormaliües at time of deep venous thrombosis
Travel 1 1
Rest at home> 12h 36
Mmor surgery 14
car 6, plane 3, bus l, otherwise l
hernia 6, malaise 6, mfection 2,
trauma 10, heavy physical exer-
tion 12
arthroscopy 6, memscectomy 2,
excision ganghon/pin knee 2, ex-
cision exostosis l, sclerosmg of






















Table 4 Resuits of the case cross-over studv
Mmor Events present before DVT absent before DVT
present m recent penod










mjunes Travel and mmor surgery had lesser contnbutions The median
mterval between the events and the thrombosis was 2 days (ränge 0-14)
The median time of the duration of the mmor event was l day (ränge
l-14 days)
Coagulation abnormaliües are summansed m Table 3 In 12 of the
61 patients (20%) with a mmor event, a hereditory abnormality of coag-
ulation was found (9 patients had a factor V Leiden) In the patients
without minor events, 40 of the 126 patients (30%) had a Coagulation
abnormality (25 factor V Leiden) Note that 3 patients who were homo-
zygotes for factor V Leiden and most of the patients with a protein C
deficiency were found m the patient group without minor e\ents
The case-cross-over study that was pertormed at approximately four
years after the initial event. dunng a follow-up investigation. is present-
ed m Table 4 Of the 187 patients, 128 could be mcluded Several
reasons existed for the exclusion of the 59 patients, ranging from
pregnancy, nontraceabihty major medical e\ents or unwillmgness to
participate Of these 128 patients. 21 had expenenced a minor event
dunng the recent two week penod preceding the time ot follow-up The
matched analysis of the presence or absence of mmor events is present-
ed in Table 4 The matched odds-ratio äs an estimate of the relative
nsk. is 2 9 (confidence mterval l 55 4)
We can restnct the case-cross-over analysis m Table 4 to those
without factor V Leiden, m order to measure the mdependent effect of
mmor events Twenty of the 128 patients camed factor V Leiden all
were among those without a recent mmor e\ent (6 ot 35 and 14 of 72)
The matched odds ratio without these patients became 2 4, which is
Table 5 Charactenstics of the mmor events m case cross-over study
Recent mmor event Patients Type of recent event Mmor event at original
(n=21) DVT (n=9)
Travel 5
















other l car l
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Table 6 Results of the case-onlv study










sufficiently dose to the overall estimate of 29, given the small
numbers
The type of minor e\ ents durmg the more recent two week penod is
presented m Table 5, together with the original minor event of the same
groups of patients Conspicuously absent from the hst of recent minor
e\ents m companson with the ones precedmg DVT is minor surgery
The relative nsk for minor surgery would therefore be very high
The synergy mdex of the mteraction between minor events and
factor V Leiden was obtamed by a case-only analysis on the original
data of DVT i e , the minor events precedmg DVT and factor V Leiden
DNA determmations In an analysis on Table 6, the odds-raüo. estimat-
mg the synergy mdex, is 0 69 with a confidence mterval of 0 31 5,
which mdicates the presence of an mcomplete multiplicative effect of
about 0 7
Discussion
Our results support the hypothesis that minor events play an im-
portant role m the cause of \ enous thrombosis To estimate the separate
effect of minoi events, we used a case-cross-over study m which the
cases w ere their own controls Four years after the venous thrombosis,
patients were asked agam if they had expenenced minor events in an
arbiträr}' two-week penod This yielded a close to 3-fold mcrease m
nsk of venous thrombosis after minor events In addition we calculated
a synergy mdex of about 0 7 between small events and factor V Leiden
If we take the mdependent nsk elevation of factor V Leiden to be
8-fold this means that the overall relative nsk of a minor event m a
person who carnes the factor V Leiden mutation will be 8 times 3 times
0 7, which amounts to a relative nsk of about 17 That jomt relative nsk
is clearly higher than the effect of each nsk factor alone, and exceeds
the sum of the relative nsks
Before accepting these estimates at face value, we have to acknowl-
edge potential strengths and weaknesses m our design The ongmal
LETS study was not designed for the aim of this investigation, the
association with minor events, however, was spontaneously noticed by
the physician or mvestigator One third of the patients had a minor
event m the weeks precedmg their DVT, which is a remarkable amount
This confirms the overall Impression of physicians that patients often
volunteer a history of minor events To study how high the frequency
really is, we used the patients äs their own controls, and asked them
about similar minor events dunng an arbitrary 2 week penod at the
occasion of a four year follow-up investigation Smce it is possible that
the ongmal spontaneous recording by physicians was elicited by some
m-depth probmg of the patients, we also probed rather m-depth dunng
the follow-up patients could mdicate on a questionnaire whether any of
the small events had been happemng recently, and they were sub-
sequently phoned to ask the details and time wmdow of these small
events. Of course, our study is possibly hampered by the increased
age and consequent changes in hfe habits of the patients. We did not
obtain follow up on all patients, although we do thmk it unhkely that
participation in the follow-up would be associated with the expenence
of a minor event Nevertheless, a bias could also be mtroduced m the
patient group due to their famihanty with the possible nsk of minor
events
A number of studies with a few cases tends to support the hypothesis
that minor events play a significant role m DVT We found at least
twenty reports m the hterature that studied the relation of thrombo-
embohsm and minor events, pubhshed between 1940 and 1998 (9-29)
Most papers were descnptions of cases or case senes and concerned
pulmonary embohsm, some with detectable DVT, mamly associated
with air travel Dunng air travel cabin related nsk factors leadmg to
hypercoagulability and hypoxia are postulated to mcrease the nsk to
develop DVT due to stasis Only few papers also descnbed the asso-
ciation with other traffic (car, tram, ship), immobilisation in theatre/
cinema, or due to effort, stram or cramped conditions in shelters
(among others 9 21, 24 27) There were few relevant larger studies
One retrospective case senes identified 44 patients with DVT related to
air flight (from a larger retrospective senes of 254 persons), of which a
minonty without known nsk factors, but also some with mjury to the
lower extremity pnor to travel (20) A recent formal case-control study
with 160 cases and the same number of controls, mvestigatmg all
modes of travel and gomg back several weeks m the history of the
patient, found that 24 5% of patients and 7 5% of controls had a history
of travel of more than five hours, leadmg to a fourfold mcrease in nsk
(4)
In our study the jomt effect of factor V Leiden and minor e\ ents was
shown to be high, at a 17 fold mcrease in nsk of the combmation This
means that additional cases of DVT occur due to the synerg) of minor
events and factor V Leiden, which would otherwise not have occurred
by either nsk factor alone One should also bear m mmd that several
nsk factors might enhance each other, e g factor V Leiden, minor
events and oral contraceptive use In a recent study m patients takmg
oral contraceptives who developed deep-vem thrombosis or pulmonar)
embohsm, the factor V Leiden and acquired nsk factors (both minor
and major events) were both found to be multiplicative nsk factors over
and beyond oral contraceptive use (30) Unfortunately, the relative
contnbution of minor and major events could not be estimated from
that study These results are important, smce a recent epidemic of
pulmonary embohsm deaths with third generation contraceptives in
New Zealand concerned a number of women who had expenenced
minor events dunng use of these contraceptives» (31) Rather than
blaming the minor e\ ents, it becomes mcreasmgly clear from our study
and several others that the concomitant use of more thrombogemc
contraceptives leads to the heightened nsk (32,33)
In conclusion, our study confirms the clmical notion that minor
events are hkely to play a role m the etiology of DVT, especially in the
presence of hereditor} thrombogemc nsk factors
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